Executive Team

Dr. Martin Gleave

Director, Vancouver Prostate Centre
Chief Executive Officer, PC-TRiADD
Distinguished Professor and Head, Department of Urologic Sciences, UBC
BC Leadership Chair in Prostate Cancer Research

 

Dr Gleave is a Distinguished Professor and Chair of the Department of Urologic Sciences at UBC, and a British Columbia Leadership Chair. He is a clinician-scientist and urologic surgeon, and Co-Founder and Executive Director of the VPC, a UBC and National Centre of Excellence, publishing > 560 papers with >47,000 citations, an H-Index of 111, and attracting >$120M in research funding. He was appointed to the Order of Canada for his leadership role in developing new treatments for prostate cancer and for his research on mechanisms mediating treatment resistance in cancer.

Dr. Larry Goldenberg

Associate Director, Development and Supportive Care, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, UBC
Stephen A. Jarislowsky Chair in Urologic Sciences at VGH

 

Dr. Goldenberg (CM, OBC, MD, FRCSC, FACS, FCAHS) is a urologic surgeon and clinical scientist with an international reputation for excellence in prostate cancer research and treatment. His current research involves the evaluation of the role of multiparametric MRI in prostate cancer, the potential use of focal therapy, patient education, daVinci robotic prostatectomy and novel treatments for benign prostatic hyperplasia. He has been recognized for his contributions to health care by being inducted into the Order of British Columbia and the Order of Canada.

Dr. Graeme Boniface

Chief Operating Officer, Vancouver Prostate Centre

 

Dr. Boniface joined the Prostate Centre in 2008 as COO, after more than 20 years in drug development in both the academic and private industry sectors. Prior to joining our Centre, he was Senior Director of Clinical Research at QLT Inc. where he oversaw the clinical development of the company’s drug platform in Oncology, Urology, Dermatology, and Endocrinology indications. Trials conducted by his team have lead to successful regulatory marketing approvals by the US FDA, Canadian, and European agencies.

Brian Shankaruk

Chief Financial Officer, Vancouver Prostate Centre
 

Brian Shankaruk has over 25 years experience in the financial field.  For 20 years prior to joining the Centre, Brian worked in the insurance and financial services industry, focusing on Canadian and US statutory government reporting.  Brian studied accounting at UBC and received his Certified General Accountant designation in 1990.  Much of Brian’s recent work has involved systems design and implementation, especially as it relates to operations management and government regulations.

Dr. Amina Zoubeidi

Senior Research Scientist, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia

 

Dr. Zoubeidi’s research program aims at uncovering how androgen receptor activity controls phenotypic plasticity, which has been associated with the clinically relevant problem of drug resistance in prostate cancer (PCa). Her multifaceted program addresses the importance of various signaling pathways in this inherently heterogeneous disease.

Dr. Cherkasov

Senior Research Scientist, Vancouver Prostate Centre
Head, Precision Cancer Drug Design, Vancouver Prostate Centre
Professor, Dept. of Urologic Sciences, University of British Columbia
Adjunct Professor, Computer Science, Simon Fraser University

 

Dr. Artem Cherkasov is a Professor in the Department of Urologic Sciences, Faculty of Medicine at the University of British Columbia, and Senior Scientist at the Vancouver Prostate Centre. His research interests include computer-aided drug discovery (CADD), structure-activity modeling, drug reprofiling, new cancer therapeutics discovery and development of novel CADD tools and applications.

Dr. Colin Collins

Senior Research Scientist, Vancouver Prostate Centre
Head, Laboratory for Advanced Genome Analysis, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia

 

Dr Collins is a Senior Research Scientist at the Vancouver Prostate Centre and a Director of The Laboratory for Advanced Genome Analysis (LAGA). In addition, he is an associate adjunct professor at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center and a visiting scientist at Lawrence Berkeley National Laboratory. He has held positions at Lawrence Livermore National Laboratory and Lawrence Berkeley National Laboratory at UCSF.

Dr. Peter Black

Senior Research Scientist, Vancouver Prostate Centre
Associate Director, Clinical Research, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia
 

Dr. Black is a surgeon scientist with clinical subspecialty interest in the treatment of urologic cancers, including especially bladder and prostate cancer. He maintains a grant-funded translational research program in urothelial carcinoma with a focus on genomic analysis of response to chemotherapy, mechanisms of resistance to chemotherapy, and novel targeted therapies for bladder cancer. One of his main laboratory projects relates to Notch signaling in bladder cancer.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

VPC Terry Fox team 2016

Terry Fox Run - September 20, 2020

The 40th annual Terry Fox Run takes place on Sunday September 20 across Canada, as a virtual event.  Please consider donating to or joining our TFRI-VPC team as we raise funds to enable The Terry Fox Foundation & The Terry Fox Research Institute to continue their support of innovative and progressive cancer research programs

Employment

Work at the Vancouver Prostate Centre

Thursday, September 24, 2020

Drs. Gleave, Lack and Wang awarded CIHR Project Grants

Tuesday, September 8, 2020

MSFHR 2020 Awardees: Drs. Hach, Gentile, Massah

Thursday, June 25, 2020

Drs. Cherkasov and Jean receive CIHR grant to find new antiviral drugs to treat COVID-19